For the Inventor, By the Inventor

Enter assignee name

Helsinki, Finland

Licentia, Ltd.

USPTO Granted Patents = 20

CIPO Patents = 3

EPO Patents = 2

Forward Citations = 151

Loading Chart...

Loading Chart...

79 inventors (with patents filed for the assignee):

Kari Alitalo (10 out of 72 patents)

Ulf Eriksson (3 out of 43 patents)

Mart Saarma (3 out of 21 patents)

4. Markku Michael Jeltsch (3 out of 10 patents)

5. Carl-Henrik Heldin (2 out of 40 patents)

6. Katri Pajusola (2 out of 9 patents)

7. Marko Uutela (2 out of 5 patents)

8. Kalle Saksela (1 out of 4 patents)

9. Raimo Tuominen (1 out of 5 patents)

10. Maria Lindahl (1 out of 4 patents)

11. Petro Suvanto (1 out of 9 patents)

12. Juha Lauren (1 out of 4 patents)

13. Tonis Timmusk (1 out of 4 patents)

14. Päivi Lindholm (1 out of 4 patents)

15. Seppo Ylä-Herttuala (1 out of 3 patents)

20 patents: Sort by Forward Citations

1. 8029984 - Materials and methods for colorectal cancer screening, diagnosis and therapy (2011-10-04),

2. 7572616 - Alternative oxidase and uses thereof (2009-08-11),

3. 7488588 - Compounds related to or derived from GFR α4 and their use (2009-02-10),

4. 7452969 - Neurotrophic factor protein and uses thereof (2008-11-18),

5. 7414023 - Peptide ligands for prostate specific antigen (2008-08-19),

6. 7355022 - Gene functionally related to dyslexia (2008-04-08),

7. 7341996 - Processed vascular endothelial growth factor-B polypeptides (2008-03-11),

8. 7309604 - Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins (2007-12-18),

9. 7160991 - Vascular endothelial growth factor polypeptides (2007-01-09),

10. 7148037 - Platelet-derived growth factor D, DNA coding therefor, and uses thereof (2006-12-12),

11. 7125714 - Progenitor cell materials and methods (2006-10-24),

12. 7105481 - Method for stimulating connective tissue growth or wound healing (2006-09-12),

13. 7034105 - FLT4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy (2006-04-25),

14. 6974816 - Combination for the treatment of endothelial damage (2005-12-13),

15. 6965010 - Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins (2005-11-15),

Licentia, Ltd. is a leading technology company specializing in software licensing solutions. With over a decade of experience, we offer innovative and efficient licensing solutions to businesses of all sizes. Our comprehensive range of products and services includes license management, software asset management, compliance tracking, and audit support. Through our cutting-edge software solutions, we help organizations streamline their licensing processes, optimize costs, and ensure compliance with industry regulations. Visit our website to learn more about our solutions and how we can assist your business.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

20 Patents

#49 in Helsinki

#161 in Finland

#30,297 in the World

Helsinki, Finland

Licentia, Ltd.

Forward Citations = 151

79 inventors:

Kari Alitalo (10 out of 72 patents)

Ulf Eriksson (3 out of 43 patents)

Mart Saarma (3 out of 21 patents)

4. Markku Michael Jeltsch (3 out of 10 patents)

5. Carl-Henrik Heldin (2 out of 40 patents)

Please report any incorrect information to support@idiyas.com

Loading…